PERSPECTA

News from every angle

← Back to headlines

Global Battle Rages for Dominance in Obesity Treatment Market

A fierce global battle is underway among European, American, and Chinese pharmaceutical companies to dominate the obesity treatment market. Novo Nordisk CEO Doustdar believes that no single player will monopolize this rapidly growing sector.

13 Aug, 15:24 — 13 Aug, 15:24
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed11d ago

Novo Nordisk CEO Doustdar says obesity drugs market won't be dominated by one player

Read full article →

Coverage Timeline

First report: seeking-alpha · 13 Aug, 15:24Full coverage: 2 · 2hWindow: 2h
Left-leaningCenterRight-leaning
seeking-alpha13 Aug, 15:24First to report

Novo Nordisk CEO Doustdar says obesity drugs market won't be dominated by one player

2h later
le-figaro13 Aug, 17:23Latest update

Labos européens, américains, chinois… La bataille mondiale des traitements contre l’obésité fait rage

Related Stories

Wall Street Futures Steady as Investors Await Nvidia Results and Fed Signals

31m ago

Meta to Launch Hatch AI Agent Platform in Coming Weeks

40m ago

Hanwha Aerospace Establishes US Unit for Global LNG Business Expansion

46m ago

Big Food Industry Fights India's Proposed 'Red Flag' Labels on Sugary Drinks and Chips

52m ago